The discrepant concordance between biopsy and radical prostatectomy (RP) specimen are well reported. To validate the clinical usefulness of neutrophil-lymphocyte ratio (NLR) in discriminating real GS ≥ 7 PCa from biopsy-based GS ≤ 6 PCa in comparison with serum total prostate-specific antigen (tPSA) and value of their combination. | The values of neutrophil-lymphocyte ratio and or prostate-specific antigen in discriminating real Gleason score 7 prostate cancer from group of biopsybased Gleason score 6
